Along with the those on the frontlines, thousands of researchers around the world are working to identify the right approach to tackling the COVID-19 pandemic from various angles and disciplines. The search for effective treatment options and vaccinations for the SARS-CoV-2 has occupied scientists and medical researchers in recent months in an unprecedented manner.

Researchers at the Bengaluru-based National Centre for Biological Sciences (NCBS) have identified 33 small molecules out of 3, 30,000 that can target one protein — NSP1 — in the Sars-Cov-2 virus, which causes Covid-19. Identifying these molecules may help with drug discovery and examining existing drugs, approved by the Food and Drug Administration (FDA), that can be repurposed to treat Covid-19.

The National Centre for Biological Sciences is pleased to welcome Sabarinathan Radhakrishnan, who joins the Centre as its newest faculty member.